Phase Ii Single Arm Study Of Durvalumab And Olaparib (D+O) In Heavily Pretreated Triple-Negative Breast Cancer (Tnbc) With Or Without Germline Brca Mutation (Gbrcam)
Durvalumab;Olaparib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase Ii Single Arm Study Of Durvalumab And Olaparib (D+O) In Heavily Pretreated Triple-Negative Breast Cancer (Tnbc) With Or Without Germline Brca Mutation (Gbrcam) ### Output: Durvalumab;Olaparib